The evolving role of partial breast irradiation in early-stage breast cancer

Annals of Surgical Oncology

Volumn 20, Issue 8, 2013, Pages 2534-2540

  Barry, Mitchel ^a   Ho, Alice ^a   Morrow, Monica ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACCELERATED PARTIAL BREAST IRRADIATION; ARTICLE; BALLOON CATHETER; BRACHYTHERAPY; BREAST CANCER; BREAST FIBROSIS; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER RECURRENCE; CLINICAL EFFECTIVENESS; EXTERNAL BEAM RADIOTHERAPY; FAT NECROSIS; FOLLOW UP; HUMAN; INFECTION; INTRABEAM DEVICE; INTRACAVITARY BRACHYTHERAPY; INTRAOPERATIVE RADIOTHERAPY; LOW ENERGY RADIATION; LOW RISK POPULATION; MULTI INTERSTITIAL BRACHYTHERAPY; MULTICATHETER INTERSTITIAL BRACHYTHERAPY; PARTIAL MASTECTOMY; PATIENT SELECTION; PHASE 2 CLINICAL TRIAL (TOPIC); PHASE 3 CLINICAL TRIAL (TOPIC); PRACTICE GUIDELINE; RADIATION DOSE; RADIATION EQUIPMENT; RADIATION RESPONSE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECURRENCE RISK; RISK REDUCTION; SEGMENTAL MASTECTOMY; SEROMA; TELANGIECTASIA; WHOLE BREAST IRRADIATION;

BRACHYTHERAPY; BREAST NEOPLASMS; CARCINOMA; FEMALE; HUMANS; INTRAOPERATIVE CARE; NEOPLASM STAGING; PATIENT SELECTION; PRACTICE GUIDELINES AS TOPIC; RADIOTHERAPY;

EID: 84880264148     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-013-2923-8     Document Type: Article

References (43)

1. Fisher B, Anderson S, Bryant J, Margolese RG, Deutsch M, Fisher ER, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med. 2002;347:1233-41.
2. Veronesi U, Cascinelli N, Mariani L, Greco M, Saccozzi R, Luini A, et al. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med. 2002;347:1227-32.
3. Fisher B, Dignam J, Wolmark N, Mamounas E, Costantino J, Poller W, et al. Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-17. J Clin Oncol. 1998;16:441-52.
4. EORTC Breast Cancer Cooperative Group, EORTC Radiotherapy Group, Bijker N, Meijnen P, Peterse JL, Bogaerts J, et al. Breast-conserving treatment with or without radiotherapy in ductal carcinoma-in situ: ten-year results of European Organisation for Research and Treatment of Cancer randomized phase III trial 10853 - a study by the EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group. J Clin Oncol. 2006;24:3381-7.
5. Early Breast Cancer Trialists' Collaborative Group (EBCTCG). Effects of the radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomized trials. Lancet. 2005;366:2087-106.
6. Malin JL, Schuster MA, Kahn KA, Brook RH. Quality of breast cancer care: what do we know? J Clin Oncol. 2002;20:4381-93.
7. Morrow M, White J, Moughan J, Owen J, Pajack T, Sylvester J, et al. Factors predicting the use of breast-conserving therapy in stage I and II breast carcinoma. J Clin Oncol. 2001;19:2254-62.
8. Kuerer HM, Julian TB, Strom EA, Lyerly HK, Giuliano AE, Mamounas EP, et al. Accelerated partial breast irradiation after conservative surgery for breast cancer. Ann Surg. 2004;239:338-51.
9. Whelan TJ, Pignol JP, Levine MN, Julian JA, MacKenzie R, Parpia S, et al. Long-term results of hypofractionated radiation therapy for breast cancer. N Engl J Med. 2010;362:513-20.
10. Fisher B, Anderson S. Conservative surgery for the management of invasive and noninvasive carcinoma of the breast: NSABP trials. National Surgical Adjuvant Breast and Bowel Project. World J Surg. 1994;18:63-9.
11. Botteri E, Bagnardi V, Rotmensz N, Gentilini O, Disalvatore D, Bazolli B, et al. Analysis of local and regional recurrences in breast cancer after conservative surgery. Ann Oncol. 2010;21:723-8.
12. Holland R, Veling SH, Mravunac M, Hendriks JH. Histologic multifocality of Tis, T1-2 breast carcinomas. Implications for clinical trials of breast-conserving surgery. Cancer. 1985;56:979-90.
13. Bartelink H, Horiot JC, Poortmans P, Struikmans H, Van den Bogaert W, Barillot I, et al.; European Organization for Research and Treatment of Cancer Radiotherapy and Breast Cancer Groups. Recurrence rates after treatment of breast cancer with standard radiotherapy with or without additional radiation. N Engl J Med. 2001;345:1378-87.
14. Polgár C, Fodor J, Major T, Németh G, Lövey K, Orosz Z, et al. Breast-conserving treatment with partial or whole breast irradiation for low-risk invasive breast carcinoma - 5-year results of a randomized trial. Int J Radiat Oncol Biol Phys. 2007;69:694-702.
15. Coles C, Yarnold J; IMPORT Trials Management Group. The IMPORT trials are launched. Clin Oncol (R Coll Radiol). 2006;18:587-90.
16. Vaidya JS, Joseph DJ, Tobias JS, Bulsara M, Wenz F, Saunders C, et al. Targeted intraoperative radiotherapy versus whole breast radiotherapy for breast cacner (TARGIT-A trial): an international, prospective, randomized, non-inferiority phase 3 trial. Lancet. 2010;376:91-102.
17. Holmes DR, Baum M, Joseph D. The TARGIT trial: targeted intra-operative radiation therapy versus conventional postoperative whole breast radiotherapy after breast conserving surgery for the management of early-stage breast cancer (a trial update). Am J Surg. 2007;194:507-10.
18. Intra M, Luini A, Gatti G, Ciocca M, Gentilini OD, Viana AA, et al. Surgical technique of intraoperative radiation therapy with electrons (ELIOT) in breast cancer: a lesson learned by over 1000 procedures. Surgery. 2006;140:467-71.
19. Pignol JP, Rakovitch E, Keller BM, Sankreacha R, Chartier C. Tolerance and acceptance results of a palladium-103 permanent breast seed implant phase I/II study. Int J Radiat Oncol Biol Phys. 2009;73:1482-8.
20. Veronesi U, Orecchia R, Luini A, Galimberti V, Zurrida S, Intra M, et al. Intra-operative radiotherapy during breast conserving surgery: a study on 1,822 cases treated with electrons. Breast Cancer Res Treat. 2010;124:141-51.
21. Leonardi MC, Maisonneuve P, Mastropasqua MG, Morra A, Lazzari R, Dell'acqua V, et al. Accelerated partial breast irradiation with intra-operative electrons: using GEC-ESTRO recommendations as guidance for patient selection. Radiother Oncol. 2013;106:21-7.
22. Antonucci JV, Wallace M, Goldstein MS, Kestin L, Chen P, Benitez P, et al. Differences in patterns of failure in patients treated with accelerated partial breast irradiation versus whole-breast irradiation; a matched pair analysis with 10-year follow up. Int J Radiat Oncol Biol Phys. 2009;74:447-52.
23. Chen PY, Vicini FA, Benitez P, Kestin LL, Wallace M, Mitchell C, et al. Long-term cosmetic results and toxicity after accelerated partial breast irradiation. Cancer. 2006;106:991-9.
24. Kuske RR, Winter K, Arthur DW, Bolton J, Rabinovitch R, White J, et al. Phase II trial of brachytherapy alone after lumpectomy for select breast cancer: toxicity analysis of RTOG 95-17. Int J Radiat Oncol Biol Phys. 2006;65:45-51.
25. Lawenda BD, Taqhian AG, Kachnic LA, Hamdi H, Smith BL, Gadd MA, et al. Dose-volume analysis of radiotherapy for T1N0 invasive breast cancer treated by local excision and partial breast irradiation by low-dose-rate interstitial implant. Int J Radiat Oncol Biol Phys. 2003;56:671-80.
26. Stewart AJ, Khan AJ, Devlin PM. Partial breast irradiation: a review of techniques and indications. Br J Radiol. 2010;83:369-78.
27. Nelson JC, Beitsch PD, Vicini FA, Quiet CA, Garcia D, Snider HC, et al. Four-year clinical update from the American Society of Breast Surgeons MammoSite brachytherapy trial. Am J Surg. 2009;198:83-91.
28. Goyal S, Khan AJ, Vicini F, Beitsch PD, Lyden M, Keisch M, et al. Factors associated with optimal cosmetic results at 36 months in patients treated with accelerated partial irradiation (APBI) on the American Society of Breast Surgeons (ASBr S) MammoXite Breast Brachytherapy Registry Trial. Ann Surg Oncol. 2009;16:2450-8.
29. Formenti SC, Truong MT, Goldberg JD, Mukhi V, Rosenstein B, Roses D, et al. Prone accelerated partial breast irradiation after breast-conserving surgery: preliminary clinical results and dose-volume histogram analysis. Int J Radiat Oncol Biol Phys. 2004;60:493-504.
30. Jagsi R, Ben-David MA, Moran JM, Marsh RB, Griffith KA, Hayman JA, et al. Unacceptable cosmesis in a protocol investigating intensity-modulated radiotherapy with active breathing control for accelerated partial-breast irradiation. Int J Radiat Oncol Biol Phys. 2010;76:71-8.
31. Shaitelman SF, Kim LH, Grills IS, Chen PY, Ye H, Kestin LL, et al. Predictors of long-term toxicity using three-dimensional conformal external beam radiotherapy to deliver accelerated partial breast irradiation. Int J Radiat Oncol Biol Phys. 2011;81:788-94.
32. Whelan TJ, Olivotto I, Parpia S, Berrang T, Kim DH, Kong I, et al. Ontario Clinical Oncology Group. Interim toxicity results from RAPID: a randomized trial of accelerated partial breast irradiation (APBI) using 3D conformal external beam radiation therapy (3D CRT). ASTRO 2012, plenary session presentation.
33. Ribeiro GG, Magee B, Swindell R, Harris M, Banerjee SS. The Christie Hospital breast conservation trial: an update at 8 years from inception. Clin Oncol. 1993;5:278-83.
34. Vicini F, Winter K, Straube W, Wong J, Pass H, Rabinovitch R, et al. A phase I/II trial to evaluate three-dimensional conformal radiation therapy confined to the region of the lumpectomy cavity for stage I/II breast carcinoma: initial report of feasibility and reproducibility of Radiation Therapy Oncology Group (RTOG) study 0319. Int J Radiat Oncol Biol Phys. 2005;63:1531-7.
35. Vicini F, Winter K, Wong J, Pass H, Rabinovitch R, Chafe S, et al. Initial efficacy results of RTOG 0319: three-dimensional conformal radiation therapy (3D-CRT) confined to the region of the lumpectomy cavity for stage I/II breast carcinoma. Int J Radiat Oncol Biol Phys. 2010;77:1120-7.
36. Chen PY, Wallace M, Mitchell C, Grills I, Kestin L, Fowler A, et al. Four-year efficacy, cosmesis, and toxicity using three-dimensional conformal external beam radiation therapy to deliver accelerated partial breast irradiation. Int J Radiat Oncol Biol Phys. 2010;76:991-7.
37. Wernicke AG, Gidea-Addeo D, Magnolfi C, Fenton-Kerimian M, Goldberg J, Formenti SC, et al. External beam partial breast irradiation following breast-conserving surgery: preliminary results of cosmetic outcome of NYU 00-23. Int J Radiat Oncol Biol Phys. 2006;66:S32A.
38. Smith BD, Arthur DW, Buchholz TA, Haffty BG, Hahn CA, Hardenbergh PH, et al. Accelerated partial breast irradiation consensus statement from the American Society for Radiation Oncology (ASTRO). Int J Radiat Oncol Biol Phys. 2009;74:987-1001.
39. Polgar C, Van Limbergen E, Potter R, Kovacs G, Polo A, Lyczek J, et al. Patient selection for accelerated partial-breast irradiation (APBI) after breast-conserving surgery; recommendations of the Groupe Europeen de Curietherapie - European Society for Therapeutic Radiology and Oncology (GEC-ESTRO) Breast Cancer Working Group based on clinical evidence (2009). Radiother Oncol. 2010;94:264-73.
40. Hughes KS, Schnaper LA, Berry D, Cirrincione C, McCormick B, Shank B, et al. Lumpectomy plus tamoxifen with or without irradiation in women 70 years of age or older with early breast cancer. N Engl J Med. 2004;351:971-7.
41. Shaitelman SF, Vicini FA, Beitsch P, Haffty B, Keisch M, Lyden M. Five-year outcome of patients classified using the American Society for Radiation Oncology consensus statement guidelines for the application of accelerated partial breast irradiation: an analysis of patients treated on the American Society of Breast Surgeons MammoSite Registry Trial. Cancer. 2010;116:4677-85.
42. Anderson SJ, Wapnir I, Dignam JJ, Fisher B, Mamounas EP, Jeong JH, et al. Prognosis after ipsilateral breast tumor recurrence and locoregional recurrences in patients treated by breast-conserving therapy in five National Surgical Adjuvant Breast and Bowel Project protocols of node-negative breast cancer. J Clin Oncol. 2009;27:2466-73.
43. Giuliano AE, McCall L, Beitsch P, Whitworth PW, Blumencranz P, Leitch AM, et al. Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: the American College of Surgeons Oncology Group Z0011 randomized trial. Ann Surg. 2010;252:426-32.